Document Detail


Development of a model to assess the cost-effectiveness of gestational diabetes mellitus screening and lifestyle change for the prevention of type 2 diabetes mellitus.
MedLine Citation:
PMID:  22099435     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Gestational diabetes mellitus (GDM) is increasingly recognized as an opportunity for early prevention of diabetes and other diseases over the lifespan, and may be responsible for up to 30% of cases of type 2 diabetes. A newly developed mathematical model (the GDModel) provides provisional estimates of the cost and health impact of various GDM screening and management choices, and calculates averted disability-adjusted life-years (DALYs). The model was piloted in 5 different healthcare facilities in India and Israel. Universal screening of pregnant women followed by postpartum lifestyle management yielded net savings of US$78 per woman with GDM in India and US$1945 per woman in Israel. The estimated DALYs averted were 2.33 in India and 3.10 in Israel. With lower GDM prevalence, intervention efficacy, and type 2 diabetes incidence, the intervention had a net cost in India, with a cost per DALY averted of US$11.32. This was far below the WHO definition of "very cost-effective," set at annual GDP per capita. The intervention in Israel remained cost-saving. GDM screening and postpartum lifestyle management are either cost-saving or have a net cost but an attractive cost-effectiveness ratio. Some input values are currently being refined. Nevertheless, the current findings of cost-savings or favorable cost-effectiveness are robust to a wide range of plausible input values, including highly unfavorable values. The GDModel will be further developed into a user-friendly tool that can guide policy-makers on decisions regarding GDM screening strategies and guidelines.
Authors:
Nicolai Lohse; Elliot Marseille; James G Kahn
Related Documents :
12643175 - Hepatic steatosis and type 2 diabetes mellitus.
21276105 - Cost of diabetes and its complications in thailand: a complete picture of economic burden.
17598085 - Long-term correction of diabetes in rats after lentiviral hepatic insulin gene therapy.
18990675 - Obstructive sleep apnea, insulin resistance, and steatohepatitis in severe obesity.
2272625 - Tracer studies of in vivo insulin action and glucose metabolism in individual periphera...
12705365 - Gestational diabetes mellitus and glucose intolerance among mexican pregnant adolescents.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics     Volume:  115 Suppl 1     ISSN:  1879-3479     ISO Abbreviation:  Int J Gynaecol Obstet     Publication Date:  2011 Nov 
Date Detail:
Created Date:  2011-11-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0210174     Medline TA:  Int J Gynaecol Obstet     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  S20-5     Citation Subset:  IM    
Copyright Information:
Copyright © 2011 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd.. All rights reserved.
Affiliation:
Global Health Partnerships, Novo Nordisk A/S, Bagsværd, Denmark.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Physiological adaption to maternal malaria and other adverse exposure: Low birth weight, functional ...
Next Document:  Matching diagnosis and management of diabetes in pregnancy to local priorities and resources: An int...